Delivery Order SPE2DB22D1103-SPE2DB24FTJC4
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,912.32, has a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The $3,375.96 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This primary vehicle...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $3,851.78 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML. This delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The $4,513.34 firm fixed price delivery order has a completion date of July 9, 2024 and was awarded on July 8, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,053.90 firm fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,837.86 Firm Fixed Price Delivery Order is for the supply of the vaccine product PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has an Ultimate Completion Date of June 6, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,526.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a completion date of February 23, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract, awarded on May 28, 2024, has a ceiling value of $3,924.55 and a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $1,673.60 firm-fixed-price contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,159.23 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a completion date of February 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the...